Linezolid salvage therapy for persistent MRSA bacteremia

In this small trial of 35 patients with persistent MRSA bacteremia (>7 days despite vancomycin treatment), those switched to linezolid had much higher response (negative cultures at 72 hours) than those continued on vancomycin + aminoglycosides or rifampin (75% versus 17%). Patients with persistent MRSA bacteremia despite vancomycin should be switched to linezolid, rather than adding adjuvant treatment to vancomycin (abstract)

This entry was posted in ID. Bookmark the permalink.

Comments are closed.